Recurrence of Dysembryoplastic Neuroepithelial Tumor following Resection (original) (raw)
Article navigation
Case Reports| June 13 2008
aDepartment of Neurosurgery, University of Michigan, Ann Arbor, Mich., and Departments of
Search for other works by this author on:
cPathology, Mayo Clinic, Rochester, Minn., USA
Search for other works by this author on:
Pediatr Neurosurg (2008) 44 (4): 333–336.
Received:
February 07 2007
Accepted:
January 24 2008
Published Online:
June 13 2008
Abstract
Dysembryoplastic neuroepithelial tumor (DNT) is an increasingly recognized surgically curable tumor that characteristically presents with seizures in children. We report a case of a patient who underwent resection of a histologically proven DNT at 6 years of age. The resection was thought to be total at the time of surgery, and this impression was confirmed on postoperative imaging. Following the initial resection, the patient underwent surveillance imaging at regular intervals. Six years following the initial surgery, surveillance imaging demonstrated an enlarging area of signal abnormality at the site of the prior resection. The patient underwent a second resection with pathological confirmation of DNT recurrence. Although recurrence of DNT following resection is rare, this case suggests that surveillance imaging may have a role in patients with DNT, even following resections that are thought to be complete.
References
Burger PC, Scheithauer BW, Vogel FS: Surgical Pathology of the Nervous System and Its Coverings, ed 4. New York, Churchill Livingstone, 2002.
Daumas-Duport C, Scheithauer BW, Chodkiewicz JP, Laws ER Jr, Vedrenne C: Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery 1988;23:545–556.
Kleihues P, Burger PC, Scheithauer BW: The new WHO classification of brain tumours. Brain Pathol 1993;3:255–268.
Prayson RA, Estes ML: Dysembryoplastic neuroepithelial tumor. Am J Clin Pathol 1992;97:398–401.
Vali AM, Clarke MA, Kelsey A: Dysembryoplastic neuroepithelial tumour as a potentially treatable cause of intractable epilepsy in children. Clin Radiol 1993;47:255–258.
Raymond AA, Halpin SF, Alsanjari N, Cook MJ, Kitchen ND, Fish DR, et al: Dysembryoplastic neuroepithelial tumor. Features in 16 patients. Brain 1994;117:461–475.
Fomekong E, Baylac F, Moret C, Chastagner P, Ducrocq X, Marchal JC: Dysembryoplastic neuroepithelial tumors. Analysis of 16 cases. Neurochirurgie 1999;45:180–189.
Daumas-Duport C, Varlet P, Bacha S, Beuvon F, Cervera-Pierot P, Chodkiewicz JP: Dysembryoplastic neuroepithelial tumors: nonspecific histological forms – A study of 40 cases. J Neurooncol 1999;41:267–280.
Ostertun B, Wolf HK, Campos MG, Matus C, Solymosi L, Elger CE, et al: Dysembryoplastic neuroepithelial tumors: MR and CT evaluation. AJNR Am J Neuroradiol 1996; 17:419–430.
Abe M, Tabuchi K, Tsuji T, Shiraishi T, Koga H, Takagi M: Dysembryoplastic neuroepithelial tumor: report of three cases. Surg Neurol 1995;43:240–245.
Prayson RA, Morris HH, Estes ML, Comair YG: Dysembryoplastic neuroepithelial tumor: a clinicopathologic and immunohistochemical study of 11 tumors including MIB1 immunoreactivity. Clin Neuropathol 1996;15:47–53.
Nolan MA, Sakuta R, Chuang N, Otsubo H, Rutka JT, Snead OC III, et al: Dysembryoplastic neuroepithelial tumors in childhood: long-term outcome and prognostic features. Neurology 2004;62:2270–2276.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
Sign in
Digital Version
Pay-Per-View Access
$39.00
1 Karger Article Bundle Token
$150
Rental
This article is also available for rental through DeepDyve. 